LncRNAs and miRNAs participate in determination of response of cancer cells to cisplatin
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNAs and miRNAs participate in determination of response of cancer cells to cisplatin
Authors
Keywords
-
Journal
EXPERIMENTAL AND MOLECULAR PATHOLOGY
Volume -, Issue -, Pages 104602
Publisher
Elsevier BV
Online
2021-01-11
DOI
10.1016/j.yexmp.2021.104602
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA‐31 weakens cisplatin resistance of medulloblastoma cells via NF‐κB and PI3K/AKT pathways
- (2020) Hui Ma et al. BIOFACTORS
- Critical roles of long noncoding RNAs in breast cancer
- (2020) Maryam Abolghasemi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
- (2020) Haiyang Zhang et al. Molecular Cancer
- miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway
- (2020) Wu Yang et al. OncoTargets and Therapy
- MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1
- (2020) Liqiang Chen et al. Bioengineered
- miR106a Promotes the Growth of Transplanted Breast Cancer and Decreases the Sensitivity of Transplanted Tumors to Cisplatin
- (2020) Faping You et al. Cancer Management and Research
- Long noncoding RNA LINC00461 mediates cisplatin resistance of rectal cancer via miR-593-5p/CCND1 axis
- (2020) Wei Qu et al. BIOMEDICINE & PHARMACOTHERAPY
- LINC00667 promotes the proliferation, migration, and pathological angiogenesis in non–small cell lung cancer through stabilizing VEGFA by EIF4A3
- (2020) Huizhen Yang et al. CELL BIOLOGY INTERNATIONAL
- LncRNA SNHG1 regulates vascular endothelial cell proliferation and angiogenesis via miR-196a
- (2020) Liping Zhang et al. JOURNAL OF MOLECULAR HISTOLOGY
- miR‑10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K/Akt pathway
- (2020) Tonghai Huang et al. ONCOLOGY REPORTS
- miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer
- (2020) Shiying Yang et al. OncoTargets and Therapy
- Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLC
- (2020) Yunyao Ye et al. OncoTargets and Therapy
- Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition
- (2020) Prathibha Kirave et al. Oncotarget
- LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway
- (2020) Qingqiang Dai et al. Cancer Management and Research
- LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/β-Catenin Pathway
- (2020) Weiwei Tang et al. Cancer Management and Research
- CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells
- (2020) Junichiro Chikuda et al. Cancers
- Downregulation of lncRNA H19 sensitizes melanoma cells to cisplatin by regulating the miR-18b/IGF1 axis
- (2020) Li-feng An et al. ANTI-CANCER DRUGS
- A nuclear lncRNA Linc00839 as a Myc target to promote breast cancer chemoresistance via PI3K/AKT signaling pathway
- (2020) Qi Chen et al. CANCER SCIENCE
- A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer
- (2020) Jing Yang et al. EXPERIMENTAL CELL RESEARCH
- PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma
- (2020) Yuting Wu et al. PHARMACOLOGICAL RESEARCH
- Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p into Endothelial Microvesicles
- (2019) Yangyang Liu et al. CIRCULATION RESEARCH
- Long Non-coding RNA DLEU1 Promotes Cell Proliferation, Invasion, and Confers Cisplatin Resistance in Bladder Cancer by Regulating the miR-99b/HS3ST3B1 Axis
- (2019) Yongzhi Li et al. Frontiers in Genetics
- MiR-126 enhances cisplatin chemosensitivity in hepatocellular carcinoma cells by targeting IRS1
- (2019) Jian Zuo et al. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
- miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes
- (2019) Xiaodi Li et al. BIOCHEMICAL PHARMACOLOGY
- MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway
- (2019) Gang Huang et al. Aging-US
- MiR-124 sensitizes cisplatin-induced cytotoxicity against CD133+ hepatocellular carcinoma cells by targeting SIRT1/ROS/JNK pathway
- (2019) Yunxiuxiu Xu et al. Aging-US
- Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204
- (2019) Hui Zhou et al. BIOMEDICINE & PHARMACOTHERAPY
- The effect of combined miR‐200c replacement and cisplatin on apoptosis induction and inhibition of gastric cancer cell line migration
- (2019) Mehri Ghasabi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9
- (2019) Chuangzhou Rao et al. BIOMEDICINE & PHARMACOTHERAPY
- Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression
- (2019) Jingjing Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis
- (2019) Jin-Tian Miao et al. BIOSCIENCE REPORTS
- MiR-1208 Increases the Sensitivity to Cisplatin by Targeting TBCK in Renal Cancer Cells
- (2019) Eun-Ae Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling
- (2019) Qiang Zhou et al. JOURNAL OF DRUG TARGETING
- lncRNA FOXD2-AS1 confers cisplatin resistance of non-small-cell lung cancer via regulation of miR185-5p–SIX1 axis
- (2019) Peng Ge et al. OncoTargets and Therapy
- Clinical Value of Circulating Microribonucleic Acids miR-1 and miR-21 in Evaluating the Diagnosis of Acute Heart Failure in Asymptomatic Type 2 Diabetic Patients
- (2019) Mutaa Abdalmutaleb Al-Hayali et al. Biomolecules
- miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway
- (2019) Tian-Liang Zheng et al. Cancer Cell International
- PCAT‐1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2
- (2019) Hui Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin
- (2019) Shuzhi Zang et al. OncoTargets and Therapy
- miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin Via Regulation Of SOS1
- (2019) Meihua Wang et al. OncoTargets and Therapy
- LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells
- (2019) Shuang Lin et al. Oncogenesis
- Up-regulated lnc-lung cancer associated transcript 1 enhances cell migration and invasion in breast cancer progression
- (2019) Ya-Lun Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2
- (2019) Carina Seidl et al. CANCER LETTERS
- MiR-21 modulates the polarization of macrophages and increases the effects of M2 macrophages on promoting the chemoresistance of ovarian cancer
- (2019) Yuanyuan An et al. LIFE SCIENCES
- Knockdown Of lncRNA NCK-AS1 Regulates Cisplatin Resistance Through Modulating miR-137 In Osteosarcoma Cells
- (2019) Yi Cheng et al. OncoTargets and Therapy
- miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin
- (2018) Qi Tang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation
- (2018) Zhixian Fang et al. BIOMEDICINE & PHARMACOTHERAPY
- Knockdown of the oncogene lncRNA NEAT1 restores the availability of miR-34c and improves the sensitivity to cisplatin in osteosarcoma
- (2018) Yuliang Hu et al. BIOSCIENCE REPORTS
- Upregulated long noncoding RNA Snhg1 promotes the angiogenesis of brain microvascular endothelial cells after oxygen–glucose deprivation treatment by targeting miR-199a
- (2018) Zhengfeng Wang et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- LncRNA NEAT1/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway
- (2018) Fei Liu et al. CANCER BIOLOGY & THERAPY
- miR-100 Reverses Cisplatin Resistance in Breast Cancer by Suppressing HAX-1
- (2018) Guojun Wu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer
- (2018) Linlin Shao et al. FASEB JOURNAL
- Genetic variants in long noncoding RNA H19 and MEG3 confer risk of type 2 diabetes in an Iranian population
- (2018) Hamid Ghaedi et al. GENE
- HOXD-AS1 exerts oncogenic functions and promotes chemoresistance in cisplatin-resistant cervical cancer cells
- (2018) Wenjie Hou et al. HUMAN GENE THERAPY
- Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a
- (2018) Chuanyao Cheng et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma
- (2018) Jinduan Lin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway
- (2018) Yangang Ma et al. NEUROCHEMISTRY INTERNATIONAL
- Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer
- (2018) Tetsuya Shindo et al. Oncotarget
- Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p
- (2018) Jingying Hou et al. Stem Cell Research & Therapy
- Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma
- (2018) Pierre-Antoine Bissey et al. Oncogenesis
- NRAL mediates cisplatin resistance in hepatocellular carcinoma via miR-340-5p/Nrf2 axis
- (2018) Li-li Wu et al. Journal of Cell Communication and Signaling
- Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer
- (2018) Tielei Tang et al. BIOMEDICINE & PHARMACOTHERAPY
- STAT3 regulatedmiR-216apromotes ovarian cancer proliferation and cisplatin resistance
- (2018) Pengfei Jin et al. BIOSCIENCE REPORTS
- The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer
- (2018) Xiaoliang Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133+ Glioblastoma Stem Cells
- (2018) Liang Yang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells
- (2018) Jiwei Guo et al. EBioMedicine
- MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells
- (2018) Lei Shi et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-338-5p inhibits cell proliferation, colony formation, migration, and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2
- (2018) Wen-Chun Lin et al. CARCINOGENESIS
- miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1
- (2018) Dandan Yi et al. CELL BIOLOGY INTERNATIONAL
- Long noncoding RNA OIP5‐AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR‐340‐5p
- (2018) Lei Song et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MiR‐34c/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin‐based chemotherapy
- (2018) Songshu Xiao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- TUG1 confers cisplatin resistance in esophageal squamous cell carcinoma by epigenetically suppressing PDCD4 expression via EZH2
- (2018) Caihui Xu et al. Cell and Bioscience
- miR-205-5p Mediated Downregulation of PTEN Contributes to Cisplatin Resistance in C13K Human Ovarian Cancer Cells
- (2018) Xiaoyan Shi et al. Frontiers in Genetics
- MicroRNA-132 upregulation promotes matrix degradation in intervertebral disc degeneration
- (2017) Wei Liu et al. EXPERIMENTAL CELL RESEARCH
- Suppression of EIF4G2 by miR-379 potentiates the cisplatin chemosensitivity in nonsmall cell lung cancer cells
- (2017) Guang-jun Hao et al. FEBS LETTERS
- Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner
- (2017) Xiaobing Qin et al. International Journal of Nanomedicine
- Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
- (2017) Peiming Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset
- (2017) M. Puthenparampil et al. Journal of Neuroinflammation
- Upregulated miR-132 in Lgr5+ gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway
- (2017) Lanfang Zhang et al. MOLECULAR CARCINOGENESIS
- Long non-coding RNA AK001796 contributes to cisplatin resistance of non-small cell lung cancer
- (2017) Bin Liu et al. Molecular Medicine Reports
- miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer
- (2017) Xijun Wang et al. ONCOLOGY REPORTS
- LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis
- (2017) Pei Wang et al. OncoTargets and Therapy
- MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer
- (2017) Huaqi Wang et al. Oncotarget
- The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin
- (2017) Xinyue Zhang et al. Oncotarget
- MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1
- (2017) Qing Xie et al. Oncotarget
- IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells
- (2017) Xiaolan Zhu et al. Oncotarget
- LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression
- (2017) Zheng Fang et al. Cancer Medicine
- Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α
- (2017) Ajimu Keremu et al. BIOSCIENCE REPORTS
- MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
- (2016) Weili Li et al. Cancer Cell International
- Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis
- (2016) Yuan Wang et al. CANCER LETTERS
- miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells
- (2016) Jing Song et al. CANCER SCIENCE
- miR-181a suppresses autophagy and sensitizes gastric cancer cells to cisplatin
- (2016) Jing Zhao et al. GENE
- MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1
- (2016) Yajie Zhang et al. International Journal of Biological Sciences
- miR-17-92 plays an oncogenic role and conveys chemo-resistance to cisplatin in human prostate cancer cells
- (2016) PENG ZHOU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells
- (2016) Li-Ping Zeng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD
- (2016) Mingxia Zhu et al. Molecular Medicine Reports
- LncRNA HOTAIR promotes cisplatin resistance in gastric cancer by targeting miR-126 to activate the PI3K/AKT/MRP1 genes
- (2016) Jin Yan et al. TUMOR BIOLOGY
- Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2
- (2016) Zhiqiang Ye et al. Oncotarget
- NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells
- (2016) Pan Jiang et al. Oncotarget
- miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET
- (2016) Qing-yong Chen et al. Oncotarget
- MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2
- (2016) Henan Zhao et al. Oncotarget
- The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer
- (2016) Zhi-Guo Zheng et al. Scientific Reports
- Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b
- (2016) Qun Fang et al. MEDICAL SCIENCE MONITOR
- Elevated HOTAIR expression associated with cisplatin resistance in non-small cell lung cancer patients
- (2016) Ming-Yue Liu et al. Journal of Thoracic Disease
- The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer
- (2015) Jian Zhao et al. BMC CANCER
- miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells
- (2015) Z Zhao et al. CANCER GENE THERAPY
- miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1
- (2015) Song Fan et al. CANCER LETTERS
- Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth
- (2015) S Adi Harel et al. CELL DEATH AND DIFFERENTIATION
- Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1
- (2015) Yangyang Ou et al. GENE
- miR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2
- (2015) XIONG CHEN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7
- (2015) Xiaoying Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression
- (2015) Chengguang Sui et al. Journal of Translational Medicine
- Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway
- (2015) YANG XIA et al. Molecular Medicine Reports
- Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1
- (2015) P Phatak et al. ONCOGENE
- miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin
- (2015) X Zhu et al. ONCOGENE
- miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy
- (2015) WENJUN YIN et al. ONCOLOGY REPORTS
- miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB
- (2015) Yiping Du et al. TUMOR BIOLOGY
- Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells
- (2015) Priya Samuel et al. TUMOR BIOLOGY
- miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis
- (2015) Sumei Zhou et al. TUMOR BIOLOGY
- Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer
- (2015) Zhiqiang Ye et al. TUMOR BIOLOGY
- miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9
- (2015) LIN WU et al. Oncology Letters
- Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1–miR-593-5p–MFF axis
- (2015) Song Fan et al. Oncotarget
- MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
- (2015) Shaohua Xu et al. Oncotarget
- MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC
- (2015) Xiaoyuan Wang et al. Scientific Reports
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist
- (2014) FUSEN PENG et al. ONCOLOGY REPORTS
- miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin
- (2014) HANG TIAN et al. ONCOLOGY REPORTS
- Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer
- (2014) HENAN ZHAO et al. ONCOLOGY REPORTS
- MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1
- (2014) Xiao He et al. TUMOR BIOLOGY
- Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2
- (2014) Ming Zhuang et al. TUMOR BIOLOGY
- Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
- (2010) Seiko Ishida et al. CANCER CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now